NYC Guidelines
Guidelines
on Assessment and Remediation
of Fungi in Indoor Environments
On
May 7, 1993, the New York City Department of Health (DOH), the New York
City Human Resources Administration (HRA), and the Mt. Sinai
Occupational Health Clinic convened an expert panel on Stachybotrys
atra in Indoor Environments. The purpose of the panel was to
develop policies for medical and environmental evaluation and
intervention to address Stachybotrys atra (now known as Stachybotrys
chartarum (SC)) contamination. The original guidelines were
developed because of mold growth problems in several New York City
buildings in the early 1990's. This document revises and expands the
original guidelines to include all fungi (mold). It is based both on a
review of the literature regarding fungi and on comments obtained by a
review panel consisting of experts in the fields of microbiology and
health sciences. It is intended for use by building engineers and
management, but is available for general distribution to anyone
concerned about fungal contamination, such as environmental consultants,
health professionals, or the general public.
We
are expanding the guidelines to be inclusive of all fungi for several
reasons:
Many
fungi (e.g., species of Aspergillus, Penicillium, Fusarium,
Trichoderma, and Memnoniella) in addition to SC can
produce potent mycotoxins, some of which are identical to compounds
produced by SC. Mycotoxins are fungal metabolites that have been
identified as toxic agents. For this reason, SC cannot be treated as
uniquely toxic in indoor environments.
People
performing renovations/cleaning of widespread fungal contamination
may be at risk for developing Organic Dust Toxic Syndrome (ODTS) or
Hypersensitivity Pneumonitis (HP). ODTS may occur after a single
heavy exposure to dust contaminated with fungi and produces
flu-like symptoms. It differs from HP in that it is not an
immune-mediated disease and does not require repeated exposures to
the same causative agent. A variety of biological agents may cause
ODTS including common species of fungi. HP may occur after repeated
exposures to an allergen and can result in permanent lung damage.
Fungi
can cause allergic reactions. The most common symptoms are runny
nose, eye irritation, cough, congestion, and aggravation of asthma.
Fungi
are present almost everywhere in indoor and outdoor environments. The
most common symptoms of fungal exposure are runny nose, eye irritation,
cough, congestion, and aggravation of asthma. Although there is evidence
documenting severe health effects of fungi in humans, most of this
evidence is derived from ingestion of contaminated foods (i.e., grain
and peanut products) or occupational exposures in agricultural settings
where inhalation exposures were very high. With the possible exception
of remediation to very heavily contaminated indoor environments, such
high-level exposures are not expected to occur while performing remedial
work.
There
have been reports linking health effects in office workers to offices
contaminated with moldy surfaces and in residents of homes contaminated
with fungal growth. Symptoms, such as fatigue, respiratory ailments, and
eye irritation were typically observed in these cases. Some studies have
suggested an association between SC and pulmonary hemorrhage/hemosiderosis
in infants, generally those less than six months old. Pulmonary
hemosiderosis is an uncommon condition that results from bleeding in the
lungs. The cause of this condition is unknown, but may result from a
combination of environmental contaminants and conditions (e.g., smoking,
fungal contaminants and other bioaerosols, and water-damaged homes), and
currently its association with SC is unproven.
The
focus of this guidance document addresses mold contamination of building
components (walls, ventilation systems, support beams, etc.) that are
chronically moist or water damaged. Occupants should address common
household sources of mold, such as mold found in bathroom tubs or
between tiles with household cleaners. Moldy food (e.g., breads, fruits,
etc.) should be discarded.
Building
materials supporting fungal growth must be remediated as rapidly as
possible in order to ensure a healthy environment. Repair of the
defects that led to water accumulation (or elevated humidity) should be
conducted in conjunction with or prior to fungal remediation. Specific
methods of assessing and remediating fungal contamination should be
based on the extent of visible contamination and underlying damage. The
simplest and most expedient remediation that is reasonable, and properly
and safely removes fungal contamination, should be used. Remediation and
assessment methods are described in this document.
The
use of respiratory protection, gloves, and eye protection is
recommended. Extensive contamination, particularly if heating,
ventilating, air conditioning (HVAC) systems or large occupied spaces
are involved, should be assessed by an experienced health and safety
professional and remediated by personnel with training and experience
handling environmentally contaminated materials. Lesser areas of
contamination can usually be assessed and remediated by building
maintenance personnel. In order to prevent contamination from recurring,
underlying defects causing moisture buildup and water damage must be
addressed. Effective communication with building occupants is an
essential component of all remedial efforts.
Fungi
in buildings may cause or exacerbate symptoms of allergies (such as
wheezing, chest tightness, shortness of breath, nasal congestion, and
eye irritation), especially in persons who have a history of allergic
diseases (such as asthma and rhinitis). Individuals with persistent
health problems that appear to be related to fungi or other bioaerosol
exposure should see their physicians for a referral to practitioners who
are trained in occupational/environmental medicine or related
specialties and are knowledgeable about these types of exposures.
Decisions about removing individuals from an affected area must be based
on the results of such medical evaluation, and be made on a case-by-case
basis. Except in cases of widespread fungal contamination that are
linked to illnesses throughout a building, building-wide evacuation is
not indicated.
In
summary, prompt remediation of contaminated material and infrastructure
repair is the primary response to fungal contamination in buildings.
Emphasis should be placed on preventing contamination through proper
building and HVAC system maintenance and prompt repair of water damage.
This
document is not a legal mandate and should be used as a guideline.
Currently there are no United States Federal, New York State, or New
York City regulations for evaluating potential health effects of fungal
contamination and remediation. These guidelines are subject to change as
more information regarding fungal contaminants becomes available.
On
May 7, 1993, the New York City Department of Health (DOH), the New York
City Human Resources Administration (HRA), and the Mt. Sinai
Occupational Health Clinic convened an expert panel on Stachybotrys
atra in Indoor Environments. The purpose of the panel was to
develop policies for medical and environmental evaluation and
intervention to address Stachybotrys atra (now known as Stachybotrys
chartarum (SC)) contamination. The original guidelines were
developed because of mold growth problems in several New York City
buildings in the early 1990's. This document revises and expands the
original guidelines to include all fungi (mold). It is based both on a
review of the literature regarding fungi and on comments obtained by a
review panel consisting of experts in the fields of microbiology and
health sciences. It is intended for use by building engineers and
management, but is available for general distribution to anyone
concerned about fungal contamination, such as environmental consultants,
health professionals, or the general public.
This
document contains a discussion of potential health effects; medical
evaluations; environmental assessments; protocols for remediation; and a
discussion of risk communication strategy. The guidelines are divided
into four sections:
1.
Health Issues; 2. Environmental Assessment; 3. Remediation; and 4.
Hazard Communication.
We
are expanding the guidelines to be inclusive of all fungi for several
reasons:
Many
fungi (e.g., species of Aspergillus, Penicillium, Fusarium,
Trichoderma, and Memnoniella) in addition to SC can
produce potent mycotoxins, some of which are identical to compounds
produced by SC.1, 2, 3, 4 Mycotoxins are fungal
metabolites that have been identified as toxic agents. For this
reason, SC cannot be treated as uniquely toxic in indoor
environments.
People
performing renovations/cleaning of widespread fungal contamination
may be at risk for developing Organic Dust Toxic Syndrome (ODTS) or
Hypersensitivity Pneumonitis (HP). ODTS may occur after a single
heavy exposure to dust contaminated with fungi and produces
flu-like symptoms. It differs from HP in that it is not an
immune-mediated disease and does not require repeated exposures to
the same causative agent. A variety of biological agents may cause
ODTS including common species of fungi. HP may occur after repeated
exposures to an allergen and can result in permanent lung damage.5,
6, 7, 8, 9, 10
Fungi
can cause allergic reactions. The most common symptoms are runny
nose, eye irritation, cough, congestion, and aggravation of asthma.11,
12
Fungi
are present almost everywhere in indoor and outdoor environments. The
most common symptoms of fungal exposure are runny nose, eye irritation,
cough, congestion, and aggravation of asthma. Although there is evidence
documenting severe health effects of fungi in humans, most of this
evidence is derived from ingestion of contaminated foods (i.e., grain
and peanut products) or occupational exposures in agricultural settings
where inhalation exposures were very high.13, 14 With the
possible exception of remediation to very heavily contaminated indoor
environments, such high level exposures are not expected to occur while
performing remedial work.15
There
have been reports linking health effects in office workers to offices
contaminated with moldy surfaces and in residents of homes contaminated
with fungal growth.12, 16, 17, 18, 19, 20 Symptoms, such as
fatigue, respiratory ailments, and eye irritation were typically
observed in these cases.
Some
studies have suggested an association between SC and pulmonary
hemorrhage/hemosiderosis in infants, generally those less than six
months old. Pulmonary hemosiderosis is an uncommon condition that
results from bleeding in the lungs. The cause of this condition is
unknown, but may result from a combination of environmental contaminants
and conditions (e.g., smoking, other microbial contaminants, and
water-damaged homes), and currently its association with SC is unproven.21,
22, 23
The
focus of this guidance document addresses mold contamination of building
components (walls, ventilation systems, support beams, etc.) that are
chronically moist or water damaged. Occupants should address common
household sources of mold, such as mold found in bathroom tubs or
between tiles with household cleaners. Moldy food (e.g., breads, fruits,
etc.) should be discarded.
This
document is not a legal mandate and should be used as a guideline.
Currently there are no United States Federal, New York State, or New
York City regulations for evaluating potential health effects of fungal
contamination and remediation. These guidelines are subject to change as
more information regarding fungal contaminants becomes available.
1.1
Health Effects
Inhalation
of fungal spores, fragments (parts), or metabolites (e.g., mycotoxins
and volatile organic compounds) from a wide variety of fungi may lead
to or exacerbate immunologic (allergic) reactions, cause toxic
effects, or cause infections.11, 12, 24
There
are only a limited number of documented cases of health problems from
indoor exposure to fungi. The intensity of exposure and health effects
seen in studies of fungal exposure in the indoor environment was
typically much less severe than those that were experienced by
agricultural workers but were of a long-term duration.5-10, 12,
14, 16-20, 25-27 Illnesses can result from both high level,
short-term exposures and lower level, long-term exposures. The most
common symptoms reported from exposures in indoor environments are
runny nose, eye irritation, cough, congestion, aggravation of asthma,
headache, and fatigue.11, 12, 16-20
The
presence of fungi on building materials as identified by a visual
assessment or by bulk/surface sampling results does not necessitate
that people will be exposed or exhibit health effects. In order for
humans to be exposed indoors, fungal spores, fragments, or metabolites
must be released into the air and inhaled, physically contacted
(dermal exposure), or ingested. Whether or not symptoms develop in
people exposed to fungi depends on the nature of the fungal material
(e.g., allergenic, toxic, or infectious), the amount of exposure, and
the susceptibility of exposed persons. Susceptibility varies with the
genetic predisposition (e.g., allergic reactions do not always occur
in all individuals), age, state of health, and concurrent exposures.
For these reasons, and because measurements of exposure are not
standardized and biological markers of exposure to fungi are largely
unknown, it is not possible to determine "safe" or
"unsafe" levels of exposure for people in general.
1.1.1
Immunological Effects
Immunological
reactions include asthma, HP, and allergic rhinitis. Contact with
fungi may also lead to dermatitis. It is thought that these conditions
are caused by an immune response to fungal agents. The most common
symptoms associated with allergic reactions are runny nose, eye
irritation, cough, congestion, and aggravation of asthma.11, 12
HP may occur after repeated exposures to an allergen and can result in
permanent lung damage. HP has typically been associated with repeated
heavy exposures in agricultural settings but has also been reported in
office settings.25, 26, 27 Exposure to fungi through
renovation work may also lead to initiation or exacerbation of
allergic or respiratory symptoms.
1.1.2
Toxic Effects
A
wide variety of symptoms have been attributed to the toxic effects of
fungi. Symptoms, such as fatigue, nausea, and headaches, and
respiratory and eye irritation have been reported. Some of the
symptoms related to fungal exposure are non-specific, such as
discomfort, inability to concentrate, and fatigue.11, 12, 16-20
Severe illnesses such as ODTS and pulmonary hemosiderosis have also
been attributed to fungal exposures.5-10, 21, 22
ODTS
describes the abrupt onset of fever, flu-like symptoms, and
respiratory symptoms in the hours following a single, heavy
exposure to dust containing organic material including fungi. It
differs from HP in that it is not an immune-mediated disease and does
not require repeated exposures to the same causative agent. ODTS may
be caused by a variety of biological agents including common species
of fungi (e.g., species of Aspergillus and Penicillium).
ODTS has been documented in farm workers handling contaminated
material but is also of concern to workers performing renovation work
on building materials contaminated with fungi.5-10
Some
studies have suggested an association between SC and pulmonary
hemorrhage/hemosiderosis in infants, generally those less than six
months old. Pulmonary hemosiderosis is an uncommon condition that
results from bleeding in the lungs. The cause of this condition is
unknown, but may result from a combination of environmental
contaminants and conditions (e.g., smoking, fungal contaminants and
other bioaerosols, and water-damaged homes), and currently its
association with SC is unproven.21, 22, 23
1.1.3
Infectious Disease
Only
a small group of fungi have been associated with infectious disease.
Aspergillosis is an infectious disease that can occur in
immunosuppressed persons. Health effects in this population can be
severe. Several species of Aspergillus are known to cause
aspergillosis. The most common is Aspergillus fumigatus.
Exposure to this common mold, even to high concentrations, is unlikely
to cause infection in a healthy person.11, 24
Exposure
to fungi associated with bird and bat droppings (e.g., Histoplasma
capsulatum and Cryptococcus neoformans) can lead to
health effects, usually transient flu-like illnesses, in healthy
individuals. Severe health effects are primarily encountered in
immunocompromised persons.24, 28, 29
1.2
Medical Evaluation
Individuals
with persistent health problems that appear to be related to fungi or
other bioaerosol exposure should see their physicians for a referral
to practitioners who are trained in occupational/environmental
medicine or related specialties and are knowledgeable about these
types of exposures. Infants (less than 12 months old) who are
experiencing non-traumatic nosebleeds or are residing in dwellings
with damp or moldy conditions and are experiencing breathing
difficulties should receive a medical evaluation to screen for
alveolar hemorrhage. Following this evaluation, infants who are
suspected of having alveolar hemorrhaging should be referred to a
pediatric pulmonologist. Infants diagnosed with pulmonary
hemosiderosis and/or pulmonary hemorrhaging should not be returned to
dwellings until remediation and air testing are completed.
Clinical
tests that can determine the source, place, or time of exposure to
fungi or their products are not currently available. Antibodies
developed by exposed persons to fungal agents can only document that
exposure has occurred. Since exposure to fungi routinely occurs in
both outdoor and indoor environments this information is of limited
value.
1.3
Medical Relocation
Infants
(less than 12 months old), persons recovering from recent surgery, or
people with immune suppression, asthma, hypersensitivity pneumonitis,
severe allergies, sinusitis, or other chronic inflammatory lung
diseases may be at greater risk for developing health problems
associated with certain fungi. Such persons should be removed from the
affected area during remediation (see Section 3,
Executive
Summary
Introduction
1. Health Issues
Remediation).
Persons diagnosed with fungal related diseases should not be returned
to the affected areas until remediation and air testing are completed.
Except in cases of widespread fungal contamination that are linked to illnesses throughout a building, a building-wide evacuation is not indicated. A trained occupational/environmental health practitioner should base decisions about medical removals in the occupational setting on the results of a clinical assessment.
Go to > Top of page
The
presence of mold, water damage, or musty odors should be addressed
immediately. In all instances, any source(s) of water must be stopped
and the extent of water damaged determined. Water damaged materials
should be dried and repaired. Mold damaged materials should be
remediated in accordance with this document (see Section 3,
2. Environmental
Assessment
-
Bulk or surface sampling is not required to undertake a remediation. Remediation (as described in Section 3, Remediation) of visually identified fungal contamination should proceed without further evaluation.
-
Bulk or surface samples may need to be collected to identify specific fungal contaminants as part of a medical evaluation if occupants are experiencing symptoms which may be related to fungal exposure or to identify the presence or absence of mold if a visual inspection is equivocal (e.g., discoloration, and staining).
-
An individual trained in appropriate sampling methodology should perform bulk or surface sampling. Bulk samples are usually collected from visibly moldy surfaces by scraping or cutting materials with a clean tool into a clean plastic bag. Surface samples are usually collected by wiping a measured area with a sterile swab or by stripping the suspect surface with clear tape. Surface sampling is less destructive than bulk sampling. Other sampling methods may also be available. A laboratory specializing in mycology should be consulted for specific sampling and delivery instructions.
-
Air sampling for fungi should not be part of a routine assessment. This is because decisions about appropriate remediation strategies can usually be made on the basis of a visual inspection. In addition, air-sampling methods for some fungi are prone to false negative results and therefore cannot be used to definitively rule out contamination.
-
Air monitoring may be necessary if an individual(s) has been diagnosed with a disease that is or may be associated with a fungal exposure (e.g., pulmonary hemorrhage/hemosiderosis, and aspergillosis).
-
Air monitoring may be necessary if there is evidence from a visual inspection or bulk sampling that ventilation systems may be contaminated. The purpose of such air monitoring is to assess the extent of contamination throughout a building. It is preferable to conduct sampling while ventilation systems are operating.
-
Air monitoring may be necessary if the presence of mold is suspected (e.g., musty odors) but cannot be identified by a visual inspection or bulk sampling (e.g., mold growth behind walls). The purpose of such air monitoring is to determine the location and/or extent of contamination.
-
If air monitoring is performed, for comparative purposes, outdoor air samples should be collected concurrently at an air intake, if possible, and at a location representative of outdoor air. For additional information on air sampling, refer to the American Conference of Governmental Industrial Hygienists' document, "Bioaerosols: Assessment and Control."
-
Personnel conducting the sampling must be trained in proper air sampling methods for microbial contaminants. A laboratory specializing in mycology should be consulted for specific sampling and shipping instructions.
2.1 Visual Inspection
A visual inspection is the most important initial step in identifying a possible contamination problem. The extent of any water damage and mold growth should be visually assessed. This assessment is important in determining remedial strategies. Ventilation systems should also be visually checked, particularly for damp filters but also for damp conditions elsewhere in the system and overall cleanliness. Ceiling tiles, gypsum wallboard (sheetrock), cardboard, paper, and other cellulosic surfaces should be given careful attention during a visual inspection. The use of equipment such as a boroscope, to view spaces in ductwork or behind walls, or a moisture meter, to detect moisture in building materials, may be helpful in identifying hidden sources of fungal growth and the extent of water damage.
2.2
Bulk/Surface Sampling
2.3
Air Monitoring
2.4 Analysis of Environmental Samples
Microscopic identification of the spores/colonies requires considerable expertise. These services are not routinely available from commercial laboratories. Documented quality control in the laboratories used for analysis of the bulk/surface and air samples is necessary. The American Industrial Hygiene Association (AIHA) offers accreditation to microbial laboratories (Environmental Microbiology Laboratory Accreditation Program (EMLAP)). Accredited laboratories must participate in quarterly proficiency testing (Environmental Microbiology Proficiency Analytical Testing Program (EMPAT)).
Evaluation of bulk/surface and air sampling data should be performed by an experienced health professional. The presence of few or trace amounts of fungal spores in bulk/surface sampling should be considered background. Amounts greater than this or the presence of fungal fragments (e.g., hyphae, and conidiophores) may suggest fungal colonization, growth, and/or accumulation at or near the sampled location.30 Air samples should be evaluated by means of comparison (i.e., indoors to outdoors) and by fungal type (e.g., genera, and species). In general, the levels and types of fungi found should be similar indoors (in non-problem buildings) as compared to the outdoor air. Differences in the levels or types of fungi found in air samples may indicate that moisture sources and resultant fungal growth may be problematic.
Go to > Top of page
In
all situations, the underlying cause of water accumulation must be
rectified or fungal growth will recur. Any initial water
infiltration should be stopped and cleaned immediately. An immediate
response (within 24 to 48 hours) and thorough clean up, drying, and/or
removal of water damaged materials will prevent or limit mold growth. If
the source of water is elevated humidity, relative humidity should be
maintained at levels below 60% to inhibit mold growth.31
Emphasis should be on ensuring proper repairs of the building
infrastructure, so that water damage and moisture buildup does not
recur.
Five
different levels of abatement are described below. The size of the area
impacted by fungal contamination primarily determines the type of
remediation. The sizing levels below are based on professional judgement
and practicality; currently there is not adequate data to relate the
extent of contamination to frequency or severity of health effects. The
goal of remediation is to remove or clean contaminated materials in a
way that prevents the emission of fungi and dust contaminated with fungi
from leaving a work area and entering an occupied or non-abatement area,
while protecting the health of workers performing the abatement. The
listed remediation methods were designed to achieve this goal, however,
due to the general nature of these methods it is the responsibility of
the people conducting remediation to ensure the methods enacted are
adequate. The listed remediation methods are not meant to exclude other
similarly effective methods. Any changes to the remediation methods
listed in these guidelines, however, should be carefully considered
prior to implementation.
Non-porous
(e.g., metals, glass, and hard plastics) and semi-porous (e.g., wood,
and concrete) materials that are structurally sound and are visibly
moldy can be cleaned and reused. Cleaning should be done using a
detergent solution. Porous materials such as ceiling tiles and
insulation, and wallboards with more than a small area of contamination
should be removed and discarded. Porous materials (e.g., wallboard, and
fabrics) that can be cleaned, can be reused, but should be discarded if
possible. A professional restoration consultant should be contacted when
restoring porous materials with more than a small area of fungal
contamination. All materials to be reused should be dry and visibly free
from mold. Routine inspections should be conducted to confirm the
effectiveness of remediation work.
The
use of gaseous, vapor-phase, or aerosolized biocides for remedial
purposes is not recommended. The use of biocides in this manner
can pose health concerns for people in occupied spaces of the building
and for people returning to the treated space if used improperly.
Furthermore, the effectiveness of these treatments is unproven and does
not address the possible health concerns from the presence of the
remaining non-viable mold. For additional information on the use of
biocides for remedial purposes, refer to the American Conference of
Governmental Industrial Hygienists' document, "Bioaerosols:
Assessment and Control."
3.1
Level I: Small Isolated Areas (10 sq. ft or less) - e.g.,
ceiling tiles, small areas on walls
Remediation
can be conducted by regular building maintenance staff. Such
persons should receive training on proper clean up methods,
personal protection, and potential health hazards. This training
can be performed as part of a program to comply with the
requirements of the OSHA Hazard Communication Standard (29 CFR
1910.1200).
Respiratory
protection (e.g., N95 disposable respirator), in accordance with
the OSHA respiratory protection standard (29 CFR 1910.134), is
recommended. Gloves and eye protection should be worn.
The
work area should be unoccupied. Vacating people from spaces
adjacent to the work area is not necessary but is recommended in
the presence of infants (less than 12 months old), persons
recovering from recent surgery, immune suppressed people, or
people with chronic inflammatory lung diseases (e.g., asthma,
hypersensitivity pneumonitis, and severe allergies).
Containment
of the work area is not necessary. Dust suppression methods, such
as misting (not soaking) surfaces prior to remediation, are
recommended.
Contaminated
materials that cannot be cleaned should be removed from the
building in a sealed plastic bag. There are no special
requirements for the disposal of moldy materials.
The
work area and areas used by remedial workers for egress should be
cleaned with a damp cloth and/or mop and a detergent solution.
All
areas should be left dry and visibly free from contamination and
debris.
3.2
Level II: Mid-Sized Isolated Areas (10 - 30 sq. ft.) -
e.g., individual wallboard panels.
Remediation
can be conducted by regular building maintenance staff. Such
persons should receive training on proper clean up methods,
personal protection, and potential health hazards. This training
can be performed as part of a program to comply with the
requirements of the OSHA Hazard Communication Standard (29 CFR
1910.1200).
Respiratory
protection (e.g., N95 disposable respirator), in accordance with
the OSHA respiratory protection standard (29 CFR 1910.134), is
recommended. Gloves and eye protection should be worn.
The
work area should be unoccupied. Vacating people from spaces
adjacent to the work area is not necessary but is recommended in
the presence of infants (less than 12 months old), persons having
undergone recent surgery, immune suppressed people, or people with
chronic inflammatory lung diseases (e.g., asthma, hypersensitivity
pneumonitis, and severe allergies).
The
work area should be covered with a plastic sheet(s) and sealed
with tape before remediation, to contain dust/debris.
Dust
suppression methods, such as misting (not soaking) surfaces prior
to remediation, are recommended.
Contaminated
materials that cannot be cleaned should be removed from the
building in sealed plastic bags. There are no special requirements
for the disposal of moldy materials.
The
work area and areas used by remedial workers for egress should be
HEPA vacuumed (a vacuum equipped with a High-Efficiency
Particulate Air filter) and cleaned with a damp cloth and/or mop
and a detergent solution.
All
areas should be left dry and visibly free from contamination and
debris.
3.3
Level III: Large Isolated Areas (30 - 100 square feet) -
e.g., several wallboard panels.
A
health and safety professional with experience performing microbial
investigations should be consulted prior to remediation activities to
provide oversight for the project.
The
following procedures at a minimum are recommended:
Personnel
trained in the handling of hazardous materials and equipped with
respiratory protection, (e.g., N95 disposable respirator), in
accordance with the OSHA respiratory protection standard (29 CFR
1910.134), is recommended. Gloves and eye protection should be
worn.
The
work area and areas directly adjacent should be covered with a
plastic sheet(s) and taped before remediation, to contain
dust/debris.
Seal
ventilation ducts/grills in the work area and areas directly
adjacent with plastic sheeting.
The
work area and areas directly adjacent should be unoccupied.
Further vacating of people from spaces near the work area is
recommended in the presence of infants (less than 12 months old),
persons having undergone recent surgery, immune suppressed people,
or people with chronic inflammatory lung diseases (e.g., asthma,
hypersensitivity pneumonitis, and severe allergies).
Dust
suppression methods, such as misting (not soaking) surfaces prior
to remediation, are recommended.
Contaminated
materials that cannot be cleaned should be removed from the
building in sealed plastic bags. There are no special requirements
for the disposal of moldy materials.
The
work area and surrounding areas should be HEPA vacuumed and
cleaned with a damp cloth and/or mop and a detergent solution.
All
areas should be left dry and visibly free from contamination and
debris.
If
abatement procedures are expected to generate a lot of dust (e.g.,
abrasive cleaning of contaminated surfaces, demolition of plaster
walls) or the visible concentration of the fungi is heavy (blanket
coverage as opposed to patchy), then it is recommended that the
remediation procedures for Level IV are followed.
3.4
Level IV: Extensive Contamination (greater than 100
contiguous square feet in an area)
A
health and safety professional with experience performing microbial
investigations should be consulted prior to remediation activities to
provide oversight for the project. The following procedures are
recommended:
Personnel
trained in the handling of hazardous materials equipped with:
Full-face
respirators with high efficiency particulate air (HEPA)
cartridges
Disposable
protective clothing covering both head and shoes
Gloves
Containment
of the affected area:
Complete
isolation of work area from occupied spaces using plastic
sheeting sealed with duct tape (including ventilation
ducts/grills, fixtures, and any other openings)
The
use of an exhaust fan with a HEPA filter to generate negative
pressurization
Airlocks
and decontamination room
Vacating
people from spaces adjacent to the work area is not necessary but
is recommended in the presence of infants (less than 12 months
old), persons having undergone recent surgery, immune suppressed
people, or people with chronic inflammatory lung diseases (e.g.,
asthma, hypersensitivity pneumonitis, and severe allergies).
Contaminated
materials that cannot be cleaned should be removed from the
building in sealed plastic bags. The outside of the bags should be
cleaned with a damp cloth and a detergent solution or HEPA
vacuumed in the decontamination chamber prior to their transport
to uncontaminated areas of the building. There are no special
requirements for the disposal of moldy materials.
The
contained area and decontamination room should be HEPA vacuumed
and cleaned with a damp cloth and/or mop with a detergent solution
and be visibly clean prior to the removal of isolation barriers.
Air
monitoring should be conducted prior to occupancy to determine if
the area is fit to reoccupy.
3.5
Level V: Remediation of HVAC Systems
3.5.1
A Small Isolated Area of Contamination (<10 square feet) in the
HVAC System
Remediation
can be conducted by regular building maintenance staff. Such
persons should receive training on proper clean up methods,
personal protection, and potential health hazards. This training
can be performed as part of a program to comply with the
requirements of the OSHA Hazard Communication Standard (29 CFR
1910.1200).
Respiratory
protection (e.g., N95 disposable respirator), in accordance with
the OSHA respiratory protection standard (29 CFR 1910.134), is
recommended. Gloves and eye protection should be worn.
The
HVAC system should be shut down prior to any remedial activities.
The
work area should be covered with a plastic sheet(s) and sealed
with tape before remediation, to contain dust/debris.
Dust
suppression methods, such as misting (not soaking) surfaces prior
to remediation, are recommended.
Growth
supporting materials that are contaminated, such as the paper on
the insulation of interior lined ducts and filters, should be
removed. Other contaminated materials that cannot be cleaned
should be removed in sealed plastic bags. There are no special
requirements for the disposal of moldy materials.
The
work area and areas immediately surrounding the work area should
be HEPA vacuumed and cleaned with a damp cloth and/or mop and a
detergent solution.
All
areas should be left dry and visibly free from contamination and
debris.
A
variety of biocides are recommended by HVAC manufacturers for use
with HVAC components, such as, cooling coils and condensation
pans. HVAC manufacturers should be consulted for the products they
recommend for use in their systems.
3.5.2
Areas of Contamination (>10 square feet) in the HVAC System
A
health and safety professional with experience performing microbial
investigations should be consulted prior to remediation activities to
provide oversight for remediation projects involving more than a small
isolated area in an HVAC system. The following procedures are
recommended:
Personnel
trained in the handling of hazardous materials equipped with:
Respiratory
protection (e.g., N95 disposable respirator), in accordance
with the OSHA respiratory protection standard (29 CFR
1910.134), is recommended.
Gloves
and eye protection
Full-face
respirators with HEPA cartridges and disposable protective
clothing covering both head and shoes should be worn if
contamination is greater than 30 square feet.
The
HVAC system should be shut down prior to any remedial activities.
Containment
of the affected area:
Complete
isolation of work area from the other areas of the HVAC system
using plastic sheeting sealed with duct tape.
The
use of an exhaust fan with a HEPA filter to generate negative
pressurization.
Airlocks
and decontamination room if contamination is greater than 30
square feet.
Growth
supporting materials that are contaminated, such as the paper on
the insulation of interior lined ducts and filters, should be
removed. Other contaminated materials that cannot be cleaned
should be removed in sealed plastic bags. When a decontamination
chamber is present, the outside of the bags should be cleaned with
a damp cloth and a detergent solution or HEPA vacuumed prior to
their transport to uncontaminated areas of the building. There are
no special requirements for the disposal of moldy materials.
The
contained area and decontamination room should be HEPA vacuumed
and cleaned with a damp cloth and/or mop and a detergent solution
prior to the removal of isolation barriers.
All
areas should be left dry and visibly free from contamination and
debris.
Air
monitoring should be conducted prior to re-occupancy with the HVAC
system in operation to determine if the area(s) served by the
system are fit to reoccupy.
A
variety of biocides are recommended by HVAC manufacturers for use
with HVAC components, such as, cooling coils and condensation
pans. HVAC manufacturers should be consulted for the products they
recommend for use in their systems.
When
fungal growth requiring large-scale remediation is found, the building
owner, management, and/or employer should notify occupants in the
affected area(s) of its presence. Notification should include a
description of the remedial measures to be taken and a timetable for
completion. Group meetings held before and after remediation with full
disclosure of plans and results can be an effective communication
mechanism. Individuals with persistent health problems that appear to be
related to bioaerosol exposure should see their physicians for a
referral to practitioners who are trained in occupational/environmental
medicine or related specialties and are knowledgeable about these types
of exposures. Individuals seeking medical attention should be provided
with a copy of all inspection results and interpretation to give to
their medical practitioners.
In
summary, the prompt remediation of contaminated material and
infrastructure repair must be the primary response to fungal
contamination in buildings. The simplest and most expedient remediation
that properly and safely removes fungal growth from buildings should be
used. In all situations, the underlying cause of water accumulation must
be rectified or the fungal growth will recur. Emphasis should be placed
on preventing contamination through proper building maintenance and
prompt repair of water damaged areas.
Widespread
contamination poses much larger problems that must be addressed on a
case-by-case basis in consultation with a health and safety specialist.
Effective communication with building occupants is an essential
component of all remedial efforts. Individuals with persistent health
problems should see their physicians for a referral to practitioners who
are trained in occupational/environmental medicine or related
specialties and are knowledgeable about these types of exposures.
Bata
A, Harrach B, Kalman U, Kis-tamas A, Lasztity R. Macrocyclic
Trichothecene Toxins Produced by Stachybotrys atra Strains
Isolated in Middle Europe. Applied and Environmental
Microbiology 1985; 49:678-81.
Jarvis
B, "Mycotoxins and Indoor Air Quality," Biological
Contaminants in Indoor Environments, ASTM STP 1071, Morey P,
Feely Sr. J, Otten J, Editors, American Society for Testing and
Materials, Philadelphia, 1990.
Yang
C, Johanning E, "Airborne Fungi and Mycotoxins," Manual
of Environmental Microbiology, Hurst C, Editor in Chief, ASM
Press, Washington, D.C., 1996
Jarvis
B, Mazzola E. Macrocyclic and Other Novel Trichothecenes: Their
Structure, Synthesis, and Biological Significance. Acc. Chem.
Res. 1982; 15:388-95.
Von
Essen S, Robbins R, Thompson A, Rennard S. Organic Dust Toxic
Syndrome: An Acute Febrile Reaction to Organic Dust Exposure
Distinct from Hypersensitivity Pneumonitis. Clinical Toxicology
1990; 28(4):389-420.
Richerson
H. Unifying Concepts Underlying the Effects of Organic Dust
Exposures. American Journal of Industrial Medicine 1990; 17:139-42.
Malmberg
P, Rask-Andersen A, Lundholm M, Palmgren U. Can Spores from Molds
and Actinomycetes Cause an Organic Dust Toxic Syndrome Reaction?. American
Journal of Industrial Medicine 1990; 17:109-10.
Malmberg
P. Health Effects of Organic Dust Exposure in Dairy Farmers. American
Journal of Industrial Medicine 1990; 17:7-15.
Yoshida
K, Masayuki A, Shukuro A. Acute Pulmonary Edema in a Storehouse of
Moldy Oranges: A Severe Case of the Organic Dust Toxic Syndrome. Archives
of Environmental Health 1989; 44(6): 382-84.
Lecours
R, Laviolette M, Cormier Y. Bronchoalveolar Lavage in Pulmonary
Mycotoxicosis. Thorax 1986; 41:924-6.
Levetin
E. "Fungi," Bioaerosols, Burge H, Editor, CRC
Press, Boca Raton, Florida, 1995.
Husman
T. Health Effects of Indoor-air Microorganisms. Scand J Work
Environ Health 1996; 22:5-13.
Miller
J D. Fungi and Mycotoxins in Grain: Implications for Stored Product
Research. J Stored Prod Res 1995; 31(1):1-16.
Cookingham
C, Solomon W. "Bioaerosol-Induced Hypersensitivity
Diseases," Bioaerosols, Burge H, Editor, CRC Press,
Boca Raton, Florida, 1995.
Rautiala
S, Reponen T, Nevalainen A, Husman T, Kalliokoski P. Control of
Exposure to Airborne Viable Microorganisms During Remediation of
Moldy Buildings; Report of Three Case Studies. American
Industrial Hygiene Association Journal 1998; 59:455-60.
Dales
R, Zwanenburg H, Burnett R, Franklin C. Respiratory Health Effects
of Home Dampness and Molds among Canadian Children. American
Journal of Epidemiology 1991; 134(2): 196-203.
Hodgson
M, Morey P, Leung W, Morrow L, Miller J D, Jarvis B, Robbins H,
Halsey J, Storey E. Building-Associated Pulmonary Disease from
Exposure to Stachybotrys chartarum and Aspergillus
versicolor. Journal of Occupational and Environmental
Medicine 1998; 40(3)241-9.
Croft
W, Jarvis B, Yatawara C. Airborne Outbreak of Trichothecene
Toxicosis. Atmospheric Environment 1986; 20(3)549-52.
DeKoster
J, Thorne P. Bioaerosol Concentrations in Noncomplaint, Complaint,
and Intervention Homes in the Midwest. American Industrial
Hygiene Association Journal 1995; 56:573-80.
Johanning
E, Biagini R, Hull D, Morey P, Jarvis B, Landbergis P. Health and
Immunological Study Following Exposure to Toxigenic Fungi (Stachybotrys
chartarum) in a Water-Damaged Office Environment. Int Arch
Occup Environ Health 1996; 68:207-18.
Montana
E, Etzel R, Allan T, Horgan T, Dearborn D. Environmental Risk Factor
Associated with Pediatric Idiopathic Pulmonary Hemorrhage and
Hemosiderosis in a Cleveland Community. Pediatrics 1997; 99(1)
Etzel
R, Montana E, Sorenson W G, Kullman G, Allan T, Dearborn D. Acute
Pulmonary Hemorrhage in Infants Associated with Exposure to Stachybotrys
atra and Other Fungi. Ach Pediatr Adolesc Med 1998; 152:757-62.
CDC.
Update: Pulmonary Hemorrhage/Hemosiderosis Among Infants ---
Cleveland, Ohio, 1993 - 1996. MMWR 2000; 49(9):
180-4.
Burge
H, Otten J. "Fungi," Bioaerosols Assessment and
Control, Macher J, Editor, American Conference of Industrial
Hygienists, Cincinnati, Ohio, 1999.
do
Pico G. Hazardous Exposure and Lung Disease Among Farm Workers. Clinics
in Chest Medicine 1992; 13(2):311-28.
Hodgson
M, Morey P, Attfield M, Sorenson W, Fink J, Rhodes W, Visvesvara G.
Pulmonary Disease Associated with Cafeteria Flooding. Archives
of Environmental Health 1985; 40(2):96-101.
Weltermann
B, Hodgson M, Storey E, DeGraff, Jr. A, Bracker A, Groseclose S,
Cole S, Cartter M, Phillips D. Hypersensitivity Pneumonitis: A
Sentinel Event Investigation in a Wet Building. American Journal
of Industrial Medicine 1998; 34:499-505.
Band
J. "Histoplasmosis," Occupational Respiratory Diseases,
Merchant J, Editor, U.S. Department of Health and Human Services,
Washington D.C., 1986.
Bertolini
R. "Histoplasmosis A Summary of the Occupational Health
Concern," Canadian Centre for Occupational Health and Safety.
Hamilton, Ontario, Canada, 1988.
Yang
C. P&K Microbiology Services, Inc. Microscopic Examination of
Sticky Tape or Bulk Samples for the Evaluation and Identification of
Fungi. Cherry Hill, New Jersey.
American
Society of Heating, Refrigerating and Air-Conditioning Engineers,
Inc. Thermal Environmental Conditions for Human Occupancy - ASHRAE
Standard (ANSI/ASHRAE 55-1992). Atlanta, Georgia, 1992.
The
New York City Department of Health would like to thank the following
individuals and organizations for participating in the revision of these
guidelines. Please note that these guidelines do not necessarily reflect
the opinions of the participants nor their organizations.
3. Remediation
Go to > Top of page
4. Hazard
Communication
Conclusion
Notes and
References
Go to > Top of page
Acknowledgments
Name |
|
Company/Institution |
Dr. Susan Klitzman |
|
Hunter College |
Dr. Philip Morey |
|
AQS Services, Inc |
Dr. Donald Ahearn |
|
Georgia State University |
Dr. Sidney Crow |
|
Georgia State University |
Dr. J. David Miller |
|
Carleton University |
Dr. Bruce Jarvis |
|
University of Maryland at College Park |
Mr. Ed Light |
|
Building Dynamics, LLC |
Dr. Chin Yang |
|
P&K Microbiology Services, Inc |
Dr. Harriet Burge |
|
Harvard School of Public Health |
Dr. Dorr Dearborn |
|
Rainbow Children's Hospital |
Mr. Eric Esswein |
|
National Institute for Occupational Safety and Health |
Dr. Ed Horn |
|
The New York State Department of Health |
Dr. Judith Schreiber |
|
The New York State Department of Health |
Mr. Gregg Recer |
|
The New York State Department of Health |
Dr. Gerald Llewellyn |
|
State of Delaware, Division of Public Health |
Mr. Daniel Price |
|
Interface Research Corporation |
Ms. Sylvia Pryce |
|
The NYC Citywide Office of Occupational Safety and Health |
Mr. Armando Chamorro |
|
Ambient Environmental |
Ms. Marie-Alix d'Halewyn |
|
Laboratoire de santé publique du Québec |
Dr. Elissa A. Favata |
|
Environmental and Occupational Health Associates |
Dr. Harriet Ammann |
|
Washington State Department of Health |
Mr. Terry Allan |
|
Cuyahoga County Board of Health |
We would also like to thank the many others who offered opinions, comments, and assistance at various stages during the development of these guidelines.
Christopher D'Andrea, M.S. of the Environmental and Occupational Disease Epidemiology Unit, was the editor of this document.
For
further information regarding this document please contact the New York
City Department of Health at (212) 788-4290 / 4288.
(April 2000) January 2002